| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.17B | +34.9% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥0.00B | — |
| Net income | ¥0.00B | — |
| Gross margin | 11.5% | Net margin 0.5% |
| Revenue Q/Q | +20.1% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.15B | 88.5% |
| R&D | ¥0.00B | 2.6% |
| SG&A | ¥0.01B | 5.7% |
| Tax & other | ¥0.00B | 0.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
瑞泰新材 ・ 普瑞眼科 ・ 宏源药业 ・ 杰创智能 ・ 威尔高 ・ 同星科技 ・ 通力科技 ・ 华融化学 ・ 普蕊斯 ・ 富士莱 ・ 艾布鲁 ・ 格力博
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies